Immunologists are at the core of understanding how the body defends itself against disease, providing essential insights that guide the development of vaccines, treatments, and diagnostics. By studying the immune system’s responses to pathogens, allergens, and even the body’s own cells, they help uncover mechanisms that can be targeted to prevent or treat illness. Their work spans both laboratory and clinical settings, where they explore cellular behavior, antibody production, and immune memory to advance medical science. Immunologists are crucial in identifying immune deficiencies, autoimmune conditions, and inflammatory disorders, which directly contributes to improving patient outcomes and quality of life.
In the field of infectious disease control, immunologists play a vital role by guiding how immune responses can be harnessed to combat viruses, bacteria, and other threats. Their research often lays the foundation for vaccine development and effectiveness testing, ensuring that immunization strategies are backed by robust scientific evidence. They collaborate with public health professionals, researchers, and biotechnologists to translate findings into practical health solutions. As new health threats emerge, immunologists continue to adapt and innovate, using cutting-edge technologies like immunogenomics and systems biology. Their contributions not only advance therapeutic science but also enhance global health resilience, making their work indispensable in both prevention and treatment strategies worldwide.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States
Title : Hypersensitivity and anti-SARS-COV-2 vaccination: A retrospective study of the year 2021 at the University Hospital Center of Tours (France)
Faure Quentin, The Savoie Metropolitan Hospital Center, France
Title : THE HPV vaccination program in Colombia. From a beautiful dream to a nightmare, but hopefully with a bright dawn.
Carlos Castro, Colombian League against cancer, Colombia